New loci associated with kidney function and chronic kidney disease.
Köttgen A., Pattaro C., Böger CA., Fuchsberger C., Olden M., Glazer NL., Parsa A., Gao X., Yang Q., Smith AV., O'Connell JR., Li M., Schmidt H., Tanaka T., Isaacs A., Ketkar S., Hwang S-J., Johnson AD., Dehghan A., Teumer A., Paré G., Atkinson EJ., Zeller T., Lohman K., Cornelis MC., Probst-Hensch NM., Kronenberg F., Tönjes A., Hayward C., Aspelund T., Eiriksdottir G., Launer LJ., Harris TB., Rampersaud E., Mitchell BD., Arking DE., Boerwinkle E., Struchalin M., Cavalieri M., Singleton A., Giallauria F., Metter J., de Boer IH., Haritunians T., Lumley T., Siscovick D., Psaty BM., Zillikens MC., Oostra BA., Feitosa M., Province M., de Andrade M., Turner ST., Schillert A., Ziegler A., Wild PS., Schnabel RB., Wilde S., Munzel TF., Leak TS., Illig T., Klopp N., Meisinger C., Wichmann H-E., Koenig W., Zgaga L., Zemunik T., Kolcic I., Minelli C., Hu FB., Johansson A., Igl W., Zaboli G., Wild SH., Wright AF., Campbell H., Ellinghaus D., Schreiber S., Aulchenko YS., Felix JF., Rivadeneira F., Uitterlinden AG., Hofman A., Imboden M., Nitsch D., Brandstätter A., Kollerits B., Kedenko L., Mägi R., Stumvoll M., Kovacs P., Boban M., Campbell S., Endlich K., Völzke H., Kroemer HK., Nauck M., Völker U., Polasek O., Vitart V., Badola S., Parker AN., Ridker PM., Kardia SLR., Blankenberg S., Liu Y., Curhan GC., Franke A., Rochat T., Paulweber B., Prokopenko I., Wang W., Gudnason V., Shuldiner AR., Coresh J., Schmidt R., Ferrucci L., Shlipak MG., van Duijn CM., Borecki I., Krämer BK., Rudan I., Gyllensten U., Wilson JF., Witteman JC., Pramstaller PP., Rettig R., Hastie N., Chasman DI., Kao WH., Heid IM., Fox CS.
Chronic kidney disease (CKD) is a significant public health problem, and recent genetic studies have identified common CKD susceptibility variants. The CKDGen consortium performed a meta-analysis of genome-wide association data in 67,093 individuals of European ancestry from 20 predominantly population-based studies in order to identify new susceptibility loci for reduced renal function as estimated by serum creatinine (eGFRcrea), serum cystatin c (eGFRcys) and CKD (eGFRcrea < 60 ml/min/1.73 m(2); n = 5,807 individuals with CKD (cases)). Follow-up of the 23 new genome-wide-significant loci (P < 5 x 10(-8)) in 22,982 replication samples identified 13 new loci affecting renal function and CKD (in or near LASS2, GCKR, ALMS1, TFDP2, DAB2, SLC34A1, VEGFA, PRKAG2, PIP5K1B, ATXN2, DACH1, UBE2Q2 and SLC7A9) and 7 loci suspected to affect creatinine production and secretion (CPS1, SLC22A2, TMEM60, WDR37, SLC6A13, WDR72 and BCAS3). These results further our understanding of the biologic mechanisms of kidney function by identifying loci that potentially influence nephrogenesis, podocyte function, angiogenesis, solute transport and metabolic functions of the kidney.